Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers

DUBLIN, Ireland, October 21, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/ssfwwf/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - Global Strategic Business Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments:

• Diagnostic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals.

The report profiles 69 companies including many key and niche players such as:

• Actinium Pharmaceuticals Inc. 
• Advanced Medical Isotope Corporation 
• Alseres Pharmaceuticals Inc. 
• Bayer HealthCare Pharmaceuticals 
• Bracco Diagnostics Inc. 
• Cardinal Health Inc. 
• Covidien Plc 
• Eli Lilly and Company 
• Erigal Limited 
• EUSA Pharma (Europe) Ltd. 
• GE Healthcare 
• IBA Group 
• Immunomedics Inc. 
• Jubilant Life Sciences Limited 
• Lantheus Medical Imaging Inc. 
• Medi-Radiopharma Ltd. 
• Nordion Inc. 
• Peregrine Pharmaceuticals Inc. 
• PETNET Solutions Inc. 
• Positron Corporation 
• Singapore Radiopharmaceuticals Pte Ltd.
• Triad Isotopes Inc.

Key Topics Covered: Click the link below to view the full extended table of contents and list of companies featured.

I. Introduction, Methodology & Product Definitions

II. Executive Summary

1. Industry Overview

2. Growth Drivers & Trends

3. Market Challenges

4. Therapeutic Radiopharmaceutical Products Under Development

5. Imaging Agents - An Overview

6. Nuclear Medicine - An Overview

7. Product Overview

8. Product Innovations/Introductions

9. Product Innovations/Introductions In Recent Past- A Perspective Builder

10. Recent Industry Activity

11. Corporate Activity In The Recent Past - A Perspective Builder

12. Focus On Select Players

13. Global Market Perspective

III. Market

1. The United States

2. Canada

3. Japan

4. Europe

5. Asia-Pacific

6. Middle East

7. Latin America

IV. Competitive Landscape

Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79)

• The United States (36)
• Canada (2)
• Japan (1)
• Europe (28)
• - France (2)
• - Germany (2)
• - The United Kingdom (4)
• - Italy (2)
• - Spain (1)
• - Rest of Europe (17)
• Asia-Pacific (Excluding Japan) (9)
• Latin America (1)
• Africa (1)
• Middle East (1)

For more information visit http://www.researchandmarkets.com/research/ssfwwf/radiopharmaceutica

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

SOURCE Research and Markets